And how does the placebo group jump from 2 % to 19 %?
Interesting. At 80 weeks the gap between 4 mg and 12 mg on weight loss is obvious, yet by 104 weeks those gaps shrink a lot, especially between 4 mg and 9 mg.
Participants on 4 mg reached nearly the same total loss as higher doses once they titrated upward after week 80, while the placebo arm showed a sharp drop once switched to active drug. Side-effect rates rose with dose but remained manageable for many; low-and-slow titration still produced solid results though slower than rapid escalation. Debate centers on whether the placebo design was methodologically sound once the control group received real drug.
What this discussion establishesWhether the placebo arm remained a true control once participants began receiving retatrutide after week 80, and whether the study design therefore confounds long-term comparisons.
Still openExact titration schedule used in the extension phase and precise exposure-time curves for each arm.
Nothing here is advice.
Interesting. At 80 weeks the gap between 4 mg and 12 mg on weight loss is obvious, yet by 104 weeks those gaps shrink a lot, especially between 4 mg and 9 mg.
And how does the placebo group jump from 2 % to 19 %?
Because everyone titrated up to their own maximum tolerated dose of reta between weeks 80 and 104, per the chart and study plan.
Some comments from a blogger who participated in the trial.
I really like that this suggests people who hit their max weight loss at 4 mg could still titrate higher in the final 24 weeks and nearly match the top dose.
By being given 9-12 mg of Reta.
I feel the same as the person who posted that. In eight months my weight dropped by twenty seven point five percent. Getting rid of the final twelve pounds required two months. The body's natural weight level resists shedding those remaining ounces intensely.
National defense concerns arise from this. America's armed forces leadership ought to provide these compounds to the current generation so they can qualify for duty. The opposing power distributes medications enhancing the enlistment candidates against them. America seems content letting its children stay heavy while their rivals assist in slimming them down. Such inconsistency baffles a true believer in the homeland.
Appreciate you sharing this. It's wild how the control participants dropped seventeen percent of their weight during those final twenty-four weeks, based on subtracting 2.2 from 19.2 at the earlier point. The higher-dose participants reached just nineteen percent reduction across the full eighty weeks, which took far longer. The control folks must have increased their dose fast and shed pounds rapidly, ending up with the same overall results as the higher dose after two full years. That's seriously impressive.
Curious whether that inert pill was really a huge laxative instead.
This means extra targets they can take out 🙄 🙄 🙄 yet the placebo facts come across as pretty unreliable in my view.
True, achieving that level of loss so quickly does look extreme. In the end though, by the time eighty weeks had passed the group was willing to starve themselves because they wanted results so badly 😂
Probably desperation pushed them to snatch a load of vials before they started stabbing wildly.
It strikes me as odd too. Yet the mind can produce genuine responses even from fake treatment.
The research approach struck me as questionable from the start. Why label participants as controls if they actually received the medication? Reports also mention some got it afterward and saw major drops in body mass. Everything about the setup felt inconsistent.
Basically the folks without the active stuff serve as the comparison until they switch something on. Those who got started on it later at the eighty week mark had stayed in the comparison part up to then. You can see the whole thing as back to back experiments where the comparison parts overlap for the inactive and the stepped up lower amounts.
I feel the same way about this. The approach looks wrong to me since once the actual medication is administered to those participants, they can't really qualify as the control set anymore. Plus, that would undermine the entire reason for having a control set initially. To properly evaluate how well the medication works across different dosing schedules and against an untouched control set, we'd need to maintain a separate group that stays without any medication at all. Does that make sense to you?
It's surprising how someone in the control group managed to drop such a big share of their weight even without getting any actual medication. That suggests they made some big shifts in their daily routines.
Why did those people stick around once they figured out they got the fake version? The cash reward must have been enough to stop them from quitting. When I mentioned the study sign-ups to my sibling he checked right away. Good thing he was ineligible because of earlier use of the medication. That sort of person isn't wanted for these studies. Knowing the usual responses he said he'd leave after just days without noticing changes.
It's puzzling how the control subjects ended up with readings at the 104 week mark that stayed fairly close to the four milligram reta bunch.
It's surprising to accept that idea since the group getting four milligrams stayed on the compound throughout the full eighty weeks while controls got nothing during that span before everyone ramped up to their highest bearable level. This setup questions the benefit of keeping reduced amounts across many weeks.
Compensation comes with joining a clinical study, whether assigned the genuine medication or a fake version. I joined one that ran for eight weeks, and it wasn't about losing weight.
Higher amounts led to noticeably stronger unwanted effects. Those findings only strengthened my decision to keep using the medication I'm on now because what happened for me beat the numbers from the comparison study and I dealt with zero problems. I lost thirty five point four percent of my body weight across fifty two weeks.
I've had none of these, and I'm on 8 mg.
I keep thinking my view might shift if I'd started with the other option at the beginning. Since this was my first choice I see it as the top option. Your take doesn't match up.
This was just a follow-up stage separate from the core study. In the main study the people getting the dummy shots continued with the inert liquid until the end. The switch happened only once that study wrapped up.
I find it noteworthy that losing more weight happened beyond the 80-week mark when the amounts were raised. This points to the leveling off being tied to the amount taken rather than merely the duration. Plus, a 25 percent incidence of throwing up at those higher levels isn't ideal.
My wife or I never even come close to the nausea feeling. We're on 8 mg Reta.
Props to those fourteen percent on the inert arm who managed to will loose stools into existence, along with the four percent who somehow conjured a bladder infection through pure suggestion.
It's good to find studies that back up gradual increases not being so harmful after all, although I still can't see how that works for those aiming to lose a lot of weight. On my end, I experienced hardly any stomach upset or throwing up even past the amounts tested. Maybe the research logs just a single occurrence across the entire duration as a side effect. The control group might balance things out though.
I figure the mind can play tricks on the body here too. When a physician keeps checking in about stomach troubles or queasiness on a regular schedule and hands over those questionnaires, it pulls your attention toward those sensations. That likely explains why so many people on the dummy version ended up feeling sick anyway.
I'm convinced the placebo effect contributes to those outcomes. My own view is that something much more basic explains the situation. Participants experienced actual stomach upset during the study but this had nothing to do with the treatment itself. It also puts the figures for the active group in better context, since those people could easily get queasy from meals or other factors whether they joined the experiment or not.
After all this time exceeding a couple years, a few episodes of queasiness don't really stand out.
What this accomplishes leaves me genuinely impressed.
At last the reason became clear for how reta 4 left me much thinner than tirz 5 ever had.
I'm hoping you could clarify what that highlighted section means. My intention is to remain at a minimal amount over an extended period, yet I'm unsure about what you're suggesting there. Appreciate it!
I pointed out how folks taking the 4mg dose dropped nearly 19 percent of their starting weight across 80 weeks while the placebo arm reached almost the same figure in only 24 weeks. That gap in duration stands out even after subtracting the small early drop the placebo group saw in the longer period. Given the option between shedding fifty pounds in half a year or the same amount over eighteen months, the quicker path would appeal to me. Plenty of people here discuss ways to push past stalls on these drugs, yet few seem interested in deliberately slowing the process. The gradual approach still delivers results, especially for those starting from a milder point. One relative of mine dropped fifty pounds on under 2mg across nine months, though she had never carried obesity long term and wouldn't have qualified for treatment under standard guidelines. My earlier remarks weren't aimed at anyone with just ten pounds left to go. With TRT plus reta and tesa in the mix, visible abs tend to appear pretty quickly.
There's a fresh entry discussing outcomes from those two late-stage trials that came out during the medical meeting, headed as a major shift for the drug in 2026.
I think they ramped up the amount for those participants until hitting the highest level each one could handle. So based on my take it wasn't kept at four milligrams once they hit the eighty week point.
No, the events didn't unfold in that manner.
Good thing I stashed reta then! I have 20 vials of 60 mg.
I see the results in another way. Those on four milligrams shed nineteen percent, unlike the twenty eight percent drop seen with twelve milligrams. Still, the four milligram participants who increased dosing to their personal maximum achieved the same twenty eight percent reduction as the twelve milligram ones during the full one hundred four weeks. The controls who also went up to their maximum tolerated amount dropped nineteen percent of body weight. Probably the controls spent less duration using the medication. Can anyone explain what I overlooked? Corrected a typing mistake.
The 4 mg dose arm of the study was on 4 mg at week 80. What you said in regards to the 4 mg group was: But the 4 mg group was on 4 mg at week 80. It went up after that.
the way levels build with passing time looks very unlike between the people on four milligrams and those on twelve. lining up the highest drops they might see for the bigger amount makes no sense when the study lengths are twenty four weeks next to one hundred four.
It copies how people really act in practice. A user picks up from online posts that smaller amounts work better so they stick with that for a long time. Then around the 80-week mark they notice things aren't improving right and bump up the amount. But by then it's too late. Those percentages don't match up exactly even though the total time is identical.
The durations spent at equivalent levels aren't matching at all. One group took 24 weeks to increase from 4mg up to 12mg, while the other remained at 12mg for 104 weeks total. To make a proper endpoint comparison, look at the increasing group's outcomes after 184 weeks, in my view.
Personally I figure the entire stretch under treatment is what counts for any fair comparison. The first batch stayed low and gradual across most of the study while the second batch increased the amount quickly yet both had identical total time exposed. The lower dose animals weren't getting nothing at all. So when someone notes the higher dose animals stayed longer at peak levels that lines up with why they dropped more body weight.
Appreciate the heads-up, I must have typed it wrong before. Just updated.
I get what you're saying. We only saw the announcement instead of the full paper. Compared to previous trials with similar medications, the way they adjusted doses here stands out. The setup for the experiment was interesting. Also, I live in the same area, down south.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.